Table 1 Correlation between SLC7A2 expression and clinicopathological characteristics in HCC patients.

From: SLC7A2 deficiency promotes hepatocellular carcinoma progression by enhancing recruitment of myeloid-derived suppressors cells

Clinicopathological variables

Tumor SLC7A2 expression

P Value

Negative (n = 53)

Positive (n = 33)

Age(years)

<55

28

21

0.224

≥55

25

12

 

Sex

Female

8

11

0.063

Male

45

22

 

Serum AFP

≤20 ng/ml

7

8

0.245

>20 ng/ml

46

25

 

Cirrrhosis

Absent

6

8

0.139

Present

47

25

 

Child-pugh score

Class A

43

29

0.552

Class B

10

4

 

Tumor number

Single

43

22

0.196

Multiple

10

11

 

Maximal tumor size

≤5 cm

24

29

<0.001*

>5 cm

29

4

 

Tumor encapsulation

Absent

28

9

0.026

Present

25

24

 

Microvascular invasion

Absent

20

19

0.080

Present

33

14

 

TNM stage

I–II

31

29

0.004*

III

22

4

 
  1. *Indicates statistical significance.
Back to article page